1. Metformin pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 polymorphisms on glycemic control and HBA1c levels;Al-Eitan;J Pers Med.,2019
2. Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: An overview;Alotaibi;Journal of Epidemiology and Global Health. Elsevier Ltd,2017
3. SLC22A1 and ATM genes polymorphisms are associated with the risk of type 2 diabetes mellitus in western Saudi Arabia: A case-control study;Altall;Application of Clinical Genetics.,2019
4. Genetic polymorphism of organic cation transporter 2 (OCT2) and its effects on the pharmacokinetics and pharmacodynamics of Metformin: a narrative review. Egyptian Journal of Medical Human Genetics. Institute for;Borra;Ionics,2023
5. Committee ADAPP, ElSayed NA, Aleppo G, Bannuru RR, Beverly EA, Bruemmer D, et al. Summary of Revisions: Standards of Care in Diabetes—2024. Diabetes Care [Internet]. 2024 Jan 1 [cited 2024 May 9];47(Supplement_1):S5–10. Available from: https://dx.doi.org/10.2337/dc24-SREV.